secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002685
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome updates corporate presentation; no financial details disclosed in filing
-------------------------------------------------------------------------------

- Axsome Therapeutics filed an 8-K on Jan 8, 2024, to announce an updated corporate presentation.
- The presentation was posted to the company's website and filed as Exhibit 99.1.
- No specific content, financial results, or guidance were provided in the filing.
- Investors should refer to the full presentation on Axsome's website for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/0000950170-24-002685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024002685/axsm-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer